{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:38:20Z","timestamp":1792028300032,"version":"4.4.0"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,10,15]]},"DOI":"10.2169\/internalmedicine.8365-21","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T22:10:02Z","timestamp":1648246202000},"page":"3083-3088","source":"Crossref","is-referenced-by-count":13,"title":["Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib"],"prefix":"10.2169","volume":"61","author":[{"given":"Saki","family":"Nakashima","sequence":"first","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"},{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Kinowaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kawada","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"},{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"},{"name":"Department of Hepatology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"},{"name":"Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenmei","family":"Takaichi","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Nephrology Center, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yamamoto Y, Matsui J, Matsushima T, et al. Lenvatinib, an angiogenesis inhibitor targeting VEGFR\/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage. Vasc Cell 6: 18, 2014.","DOI":"10.1186\/2045-824X-6-18"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Schlumberger M, Tahara M, Wirth LJ, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372: 621-630, 2015.","DOI":"10.1056\/NEJMoa1406470"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Med 9: 669-676, 2003.","DOI":"10.1038\/nm0603-669"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003.","DOI":"10.1172\/JCI17423"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Karkkainen MJ, M\u00e4kinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nature Cell Biol 4: E2-E5, 2002.","DOI":"10.1038\/ncb0102-e2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Furuto Y, Hashimoto H, Namikawa A, et al. Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report. BMC Nephrol 19: 273, 2018.","DOI":"10.1186\/s12882-018-1074-3"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391: 1163-1173, 2018.","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Izzedine H, Mangier M, Ory V, et al. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. Kidney Int 85: 457-470, 2014.","DOI":"10.1038\/ki.2013.344"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Haddad RI, Schlumberger M, Wirth LJ, et al. Incidence and timing of common adverse events in lenvatinib-treated patients from the SELECT trial and their association with survival outcomes. Endocrine 56: 121-128, 2017.","DOI":"10.1007\/s12020-017-1233-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schiessl IM, Grill A, Fremter K, Steppan D, Hellmuth MK, Castrop H. Renal interstitial platelet-derived growth factor receptor-\u03b2 cells support proximal tubular regeneration. J Am Soc Nephrol 29: 1383-1396, 2018.","DOI":"10.1681\/ASN.2017101069"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takikita-Suzuki M, Haneda M, Sasahara M, et al. Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury. Am J Pathol 163: 277-286, 2003.","DOI":"10.1016\/S0002-9440(10)63651-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 57: 297-309, 1995.","DOI":"10.1146\/annurev.ph.57.030195.001501"},{"key":"13","unstructured":"13. Delsante M, Monroy-Trujillo JM, Carter-Monroe N, Ball DW, Rosenberg AZ. Lenvatinib-related renal microangiopathy: a case series. Virchows Arch. Forthcoming."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cavalieri S, Cosmai L, Genderini A, et al. Lenvatinib-induced renal failure: two first-time case reports and review of literature. Expert Opin Drug Metab Toxicol 14: 379-385, 2018.","DOI":"10.1080\/17425255.2018.1461839"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fleming K, McGuinness J, Kipgen D, Glen H, Spiliopoulou P. A case of lenvatinib-induced focal segmental glomerulosclerosis (FSGS) in metastatic medullary thyroid cancer. Case Rep Oncol Med 2018: 6927639, 2018.","DOI":"10.1155\/2018\/6927639"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Boor P, van Roeyen CR, Kunter U, et al. PDGF-C mediates glomerular capillary repair. Am J Pathol 177: 58-69, 2010.","DOI":"10.2353\/ajpath.2010.091008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Izzedine H, Perazella MA. Thrombotic microangiopathy, cancer, and cancer drugs. Am J Kidney Dis 66: 857-868, 2015.","DOI":"10.1053\/j.ajkd.2015.02.340"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Toriu N, Sekine A, Mizuno H, et al. Renal-limited thrombotic microangiopathy due to bevacizumab therapy for metastatic colorectal cancer: a case report. Case Rep Oncol 12: 391-400, 2019.","DOI":"10.1159\/000500716"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shima N, Sawa N, Yamanouchi M, et al. Characteristic renal histology of a 81-year-old patient with a 30-year history of diabetes mellitus: a case report. CEN Case Rep 9: 338-343, 2020.","DOI":"10.1007\/s13730-020-00483-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/20\/61_8365-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:30:26Z","timestamp":1715315426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/20\/61_8365-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":19,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8365-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"article-number":"8365-21"}}